Intuitive Surgical, Inc. vs ResMed Inc., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ISRG and RMD diverge most: on debt / equity, ISRG reads 0.00 and RMD reads 0.10; on ev/ebitda, ISRG reads 42.6 and RMD reads 15.7. The rest of the comparable metrics sit closer together. What ISRG's price implies is a somewhat stretched bet versus history (whole-company basis). What RMD's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | ISRG | RMD |
|---|---|---|
| Price | $423.92 | $230.14 |
| Market cap | $151.5B | $33.5B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Mature |
| Implied growth (priced in) | — | +8.5% |
| P/E | 48.7 | 22.1 |
| P/B | 8.28 | 5.09 |
| P/S | 13.73 | 5.93 |
| EV/EBITDA | 42.6 | 15.7 |
| Revenue growth | +20.8% | +9.9% |
| Gross margin | 67.8% | 58.8% |
| Operating margin | 33.6% | 30.7% |
| Net margin | 28.4% | 26.9% |
| Return on equity | 17.1% | 23.1% |
| Return on assets | 15.0% | 17.0% |
| Return on invested capital | 14.7% | 21.1% |
| FCF yield | 2.1% | 4.9% |
| Dividend yield | — | 1.0% |
| Debt / equity | 0.00 | 0.10 |
| Current ratio | 4.96 | 3.10 |
| Altman Z (solvency) | 7.58 | 8.32 |
| Piotroski F (quality) | 7 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.